Table 4.

Laboratory assays in the study group, depending on the line of disease-modifying therapy.

	LI	LII	p
	N = 44	N = 19
NOx a [µM]	2.04 ± 0.70	1.57 ± 0.31	0.003
IL-1β/IL-1F2b [pg/mL]	1.51 ± 0.46	1.76 ± 0.92	0.81
CRPc [mg/L]	2.13 ± 2.47	1.49 ± 2.05	0.06

A: nitric oxide (nitrite and nitrate); b: interleukin; c: C-reactive protein.